NcRNA-Mediated High Expression of as a Prognostic Biomarker Correlated With Cell Proliferation and Cell Migration in Lung Adenocarcinoma.

Background: Hyaluronan-mediated motility receptor () plays a pivotal role in cell proliferation in various cancers, including lung cancer. However, its function and biological mechanism in lung adenocarcinoma (LUAD) remain unclear.

Methods: Data on expression from several public databases were extensively analyzed, including the prognosis of in the Gene Expression Profiling Interactive Analysis (GEPIA) database.

MiR-4429 Alleviates Malignant Behaviors of Lung Adenocarcioma Through Pathway.

Lung adenocarcinoma (ADC) is a common subtype of non-small cell lung cancer. MicroRNAs have been reported to be effective biomarkers for diagnosis and an important target for therapy. MiR-4429 is a newly identified miRNA, which can take part in tumor progression as a tumor inhibitor.

[Levels of activation markers of platelets in peripheral blood and their significance in patients with lung cancer].

Background: Platelet activation often occurs in intermediate and advanced tumors, with increases of expression and release of platelet adhesion molecule. The aim of this study is to investigate the expression of activation markers of platelet and their significance in lung cancer.

Methods: The activation markers of platelet, CD62P and CD63, were detected in peripheral blood of 120 patients with lung cancer and 60 healthy persons by FCM method.